Sector: Pharmaceuticals & Biotechnology

Small Cap

Novartis Share Price

Novartis India Ltd.

₹954.95

-49.85(-4.96%)

Invest in NOVARTIND with up to 2.50x margin.

Trade with MTF

24th Feb 2026 | 10:14 AM

NSE :

Open Free Demat Account

Novartis Performance

Price Movement

N/A

₹950.30

₹994.70

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹994.70

Low₹950.30

Open at₹984.00

Prev Close₹1,004.80

Volumes12.60 K

Avg Price₹966.40

Lower Circuit₹803.85

Upper Circuit₹1,205.75

Historical Performance

3M High₹1,074.00

3M Low₹750.00

1 Yr High₹1,099.90

1 Yr Low₹744.95

3 Yr High₹1,248.00

3 Yr Low₹554.00

5 Yr High₹1,248.00

5 Yr Low₹538.05

Novartis Fundamentals

Market Cap

Above industry Median

2,480.90 Cr.

PE Ratio (TTM)

Above industry Median

25.50

Dividend Yield

High in industry

2.50

Net Profit TTM

12.7% incr over last year

97.23

Net Profit Growth

12.7% incr over last year

97.23

PEG Ratio

High in industry

ROE

12.4% incr over last year

12.85

Operating Revenue TTM

347.66

Operating Revenue Growth

2% decr over last year

Book Value

Above industry Median

3.20

MFI

MFI strongly Overbought

98.17

RSI

RSI Overbought

78.01

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

3.20

Novartis Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	85.90	90.33	87.55	83.88	93
Operating Expense	63.54	66.45	60.34	60.17	67.42
Operating Profit	22.36	23.88	27.24	23.91	25.58
Depreciation	0.48	0.52	0.53	0.53	0.53
Interest	0.98	0.11	0.10	0.12	0.36
Tax	13.56	8.43	9.60	4.59	9.84
Net Profit	16.09	24.22	27.62	29.30	25.45

Novartis Technicals

Novartis India Ltd. EMA & SMA

₹954.95

-41.55 (-4.17%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹925.6

Day EMA10 ₹882.8

Day EMA12 ₹872.8

Day EMA20 ₹848

Day EMA26 ₹837.7

Day EMA50 ₹823.3

Day EMA100 ₹834

Day EMA200 ₹864.3

Novartis Support and Resistance

Resistance

First Resistance₹1059.17

Second Resistance₹1113.53

Third Resistance₹1153.07

Support

First Support₹965.27

Second Support₹925.73

Third Support₹871.37

Technical Indicators

Day RSI78.01

Day MFI98.17

Day ADX26.28

Day Commodity Channel Index331.80

William-22.79

Day MACD35.19

Day MACD Signal Line16.56

Day ATR40.79

Day ROC1259.93

Day ROC2127.81

Novartis Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	70.7	70.7	70.7	70.7	70.7	70.7
FII	0.2	0.2	0.2	0.2	0.2	0.2
DII	0.5	0.5	0.5	0.5	0.5	0.6
Public	28.6	28.6	28.6	28.6	28.6	28.5

Novartis Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	3.42 L	10.34 L	33.05%
Week	90.96 K	2.43 L	37.40%
1 Month	26.43 K	63.99 K	41.31%
6 Month	8.31 K	16.71 K	49.71%

Novartis SWOT Analysis

Strengths22

Weakness5

Opportunity4

Threats0

Companies with no Debt

Benjamin Graham Value Screen

Strong Momentum: Price above short, medium and long term moving averages

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Stocks whose current price is 20% higher than week low, and more than previous close

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Stock gained more than 20% in one month

Biggest Price Gainers from Open

Top Gainers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Novartis Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
23 Jul, 2025	25	FINAL	23 Jul, 2025	Equity Share
23 Jul, 2024	25	FINAL		Equity Share
20 Jul, 2023	37.5	SPECIAL		Equity Share
20 Jul, 2023	10	FINAL		Equity Share
20 Jul, 2022	10	FINAL		Equity Share
17 Aug, 2021	10	FINAL		Equity Share
29 Jul, 2020	10	FINAL		Equity Share
31 Jul, 2019	10	FINAL		Equity Share
18 Jul, 2018	10	FINAL		Equity Share
19 Jul, 2017	10	FINAL		Equity Share

Novartis Stock Comparison

Financials	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Aptus Pharma Ltd.	Amanta Healthcare Ltd.
Price (₹)	₹183	₹25.08	₹8.18	₹96.65	₹256.35	₹102.99
% Change	0.00%	0.00%	-2.97%	0.00%	0.00%	-1.29%
Revenue TTM (₹ Cr)	-	₹0.54	₹104.12	-	-	₹282.74
Net Profit TTM (₹ Cr)	-	₹-0.24	₹-24.37	-	-	₹15.30
PE TTM	50.70	-63.80	-2.90	12.80	56.70	26.50
1 Year Return		457.33	743	-24.49		-17.19
ROCE	-	-	-5.63	-	-	-

Similar Stocks

AHCL

Anlon Healthcare Ltd.

₹ 114.50

-1.52%

MEDISTEP

Medistep Healthcare Ltd.

₹ 22.60

+0.00%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 71.00

-0.98%

APL

Asston Pharmaceuticals Ltd.

₹ 81.00

-1.22%

INFLUX

Influx Healthtech Ltd.

₹ 208.00

-0.31%

MEDIORG

Medicamen Organics Ltd.

₹ 25.00

+0.00%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 607.05

+0.55%

ASTONEALAB

Astonea Labs Ltd.

₹ 160.00

+0.00%

AMWILL

Amwill Health Care Ltd.

₹ 34.55

-4.03%

SENORES

Senores Pharmaceuticals Ltd.

₹ 789.35

-0.56%

INNOVACAP

Innova Captab Ltd.

₹ 675.35

-1.24%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 59.11

+0.02%

SHELTER

Shelter Pharma Ltd.

₹ 37.33

-0.29%

TLL

Trident Lifeline Ltd.

₹ 254.00

+0.00%

DPL

Dipna Pharmachem Ltd.

₹ 10.00

+0.00%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.45

+3.02%

SIGACHI

Sigachi Industries Ltd.

₹ 20.98

-0.85%

WINDLAS

Windlas Biotech Ltd.

₹ 767.80

-0.47%

VINEETLAB

Vineet Laboratories Ltd.

₹ 31.31

-2.25%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 40.10

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 467.00

-1.12%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.46

-2.13%

ZIMLAB

Zim Laboratories Ltd.

₹ 68.88

-1.63%

FAQ's on NOVARTIND

What is the Market Capitalization of Novartis India Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Novartis India Ltd. is approximately ₹ 2480.9 Cr.

What are the PE and PB ratios for Novartis India Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Novartis India Ltd. is 25.5, and the Price-to-Book (PB) ratio is 3.2.

What is the 52-Week High and Low for Novartis India Ltd.?

Over the past 52 weeks, the highest price reached by Novartis India Ltd. shares was ₹ 1099.9, and the lowest price was ₹ 744.95.

What is the current dividend yield for Novartis India Ltd.?

As of 6 June 2025, the dividend yield for Novartis India Ltd. is 2.5%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Novartis India Ltd.?

Significant shareholdings in Novartis India Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Novartis India Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Novartis India Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Novartis India Ltd.?

Novartis India Ltd. last declared a FINAL dividend of ₹ 25 per share for the financial period ending 2025. The record date was set as 2025-07-23, and the payment was/is scheduled around 2025-07-23. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy